The role of HMGB1/RAGE in inflammatory cardiomyopathy

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 2, 2010, Pages 185-194

  Volz, Hans C ^a   Kaya, Ziya ^a   Katus, Hugo A ^a   Andrassy, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HMGB1; Inflammation; Inflammatory cardiomyopathy; Innate immunity

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOMYOPATHY; CELL DEATH; CLINICAL PRACTICE; CYTOKINE PRODUCTION; DISEASE COURSE; DRESSLER SYNDROME; HEART FAILURE; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW;

CARDIOMYOPATHIES; HMGB1 PROTEIN; HUMANS; INFLAMMATION; RECEPTORS, IMMUNOLOGIC;

EID: 77951545792     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1251503     Document Type: Review

References (46)

1. Alla F, Zannad F, Filippatos G. Epidemiology of acute heart failure syndromes. Heart Fail Rev 2007 12 (2) 91-95 (Pubitemid 46916953)
2. Schocken D D., Benjamin E J., Fonarow G C. et al, American Heart Association Council on Epidemiology and Prevention American Heart Association Council on Clinical Cardiology American Heart Association Council on Cardiovascular Nursing American Heart Association Council on High Blood Pressure Research Quality of Care and Outcomes Research Interdisciplinary Working Group Functional Genomics and Translational Biology Interdisciplinary Working Group. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008 117 (19) 2544-2565 (Pubitemid 351670463)
3. Rauchhaus M, Doehner W, Francis D P. et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000 102 (25) 3060-3067
4. Deswal A, Petersen N J., Feldman A M., Young J B., White B G., Mann D L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001 103 (16) 2055-2059 (Pubitemid 32373007)
5. Kandolf R. Myocarditis and cardiomyopathy [in German]. Verh Dtsch Ges Pathol 1996 80 127-138
6. Pisani B, Taylor D O., Mason J W. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 1997 102 (5) 459-469 (Pubitemid 27280483)
7. Feldman A M., McNamara D. Myocarditis. N Engl J Med 2000 343 (19) 1388-1398
8. Kindermann I, Kindermann M, Kandolf R et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008 118 (6) 639-648
9. D'Ambrosio A, Patti G, Manzoli A et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001 85 (5) 499-504 (Pubitemid 32973488)
10. Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996 93 (5) 841-842 (Pubitemid 26074816)
11. Codd M B., Sugrue D D., Gersh B J., Melton L J. III. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 19751984. Circulation 1989 80 (3) 564-572
12. Cowie M R., Mosterd A, Wood D A. et al. The epidemiology of heart failure. Eur Heart J 1997 18 (2) 208-225 (Pubitemid 27107582)
13. Smith S C., Allen P M. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991 147 (7) 2141-2147
14. Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995 181 (3) 1123-1131
15. Huber S A., Lodge P A. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 1986 122 (2) 284-291
16. Kaya Z, Afanasyeva M, Wang Y et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol 2001 2 (8) 739-745 (Pubitemid 32747164)
17. Park J S., Arcaroli J, Yum H K. et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003 284 (4) C870-C879 (Pubitemid 36336943)
18. Scaffidi P, Misteli T, Bianchi M E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002 418 (6894) 191-195 (Pubitemid 34773774)
19. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999 285 (5425) 248-251 (Pubitemid 29329996)
20. Andersson U, Wang H, Palmblad K et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000 192 (4) 565-570 (Pubitemid 30666257)
21. Treutiger C J., Mullins G E., Johansson A S. et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003 254 (4) 375-385
22. Rovere-Querini P, Capobianco A, Scaffidi P et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004 5 (8) 825-830 (Pubitemid 39199174)
23. Yang H, Ochani M, Li J et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004 101 (1) 296-301 (Pubitemid 38084244)
24. Andrassy M, Volz H C., Igwe J C. et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008 117 (25) 3216-3226 (Pubitemid 351492503)
25. Kokkola R, Sundberg E, Ulfgren A K. et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002 46 (10) 2598-2603 (Pubitemid 36118922)
26. Ulfgren A K., Grundtman C, Borg K et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 2004 50 (5) 1586-1594 (Pubitemid 38608081)
27. Park L, Raman K G., Lee K J. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998 4 (9) 1025-1031 (Pubitemid 28417334)
28. Bierhaus A, Haslbeck K M., Humpert P M. et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004 114 (12) 1741-1751 (Pubitemid 40385530)
29. Haslbeck K M., Bierhaus A, Erwin S et al. Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve 2004 29 (6) 853-860 (Pubitemid 38720822)
30. Haslbeck K M., Friess U, Schleicher E D. et al. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Acta Neuropathol 2005 110 (3) 247-254 (Pubitemid 41430653)
31. Sakaguchi T, Yan S F., Yan S D. et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003 111 (7) 959-972 (Pubitemid 36397472)
32. Andrassy M, Igwe J, Autschbach F et al. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 2006 169 (4) 1223-1237 (Pubitemid 351194359)
33. Yan S F., Ramasamy R, Naka Y, Schmidt A M. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003 93 (12) 1159-1169 (Pubitemid 37543056)
34. Hori O, Brett J, Slattery T et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995 270 (43) 25752-25761
35. Kokkola R, Andersson A, Mullins G et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005 61 (1) 1-9
36. Yang D, Chen Q, Yang H, Tracey K J., Bustin M, Oppenheim J J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007 81 (1) 59-66 (Pubitemid 46021253)
37. Dumitriu I E., Baruah P, Valentinis B et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005 174 (12) 7506-7515 (Pubitemid 40806253)
38. Jaulmes A, Thierry S, Janvier B, Raymondjean M, Marchal V. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J 2006 20 (10) 1727-1729 (Pubitemid 44961984)
39. Fiuza C, Bustin M, Talwar S et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003 101 (7) 2652-2660 (Pubitemid 36857626)
40. Mitola S, Belleri M, Urbinati C et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 2006 176 (1) 12-15 (Pubitemid 43023243)
41. Huttunen H J., Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999 274 (28) 19919-19924 (Pubitemid 129519445)
42. Bierhaus A, Schiekofer S, Schwaninger M et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001 50 (12) 2792-2808 (Pubitemid 33733131)
43. Li J, Schmidt A M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997 272 (26) 16498-16506 (Pubitemid 27276477)
44. Harja E, Bu D X., Hudson B I. et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest 2008 118 (1) 183-194
45. Gser S, Andrassy M, Buss S J. et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006 114 (16) 1693-1702 (Pubitemid 44607117)
46. Liang Y, Zhou Y, Shen P. NF-kappaB and its regulation on the immune system. Cell Mol Immunol 2004 1 (5) 343-350